Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Where Next for British American Tobacco PLC (BTI)’s Dividend?

Page 1 of 2

LONDON — Many investors focus on earnings per share when judging a company’s performance. However, earnings can be manipulated and adjusted in all sorts of ways, meaning they don’t tell you a lot about how much spare cash a company has generated. Similarly, because dividend cover is calculated using earnings, a good level of dividend cover doesn’t necessarily mean the payout is actually being funded from a company’s profits.

A company’s cash flow can tell you a lot about a firm’s financial health. Is the company burning up its cash reserves on interest payments and operating expenses, or does it generate spare cash that can fund dividends or be retained for future investment? If a dividend isn’t funded by cash flow, then there is a greater chance the payout will become unaffordable and be cut, which is bad news for shareholders like you and I.

British American Tobacco PLC (ADR) (NYSEAMEX:BTI)

In this series, I’m going to take a look at the cash flow statements of some of the biggest names in the FTSE 100 to see whether their dividends are being funded in a sustainable way — from genuine spare cash. Today, I’m looking at income favorite British American Tobacco PLC (NYSEMKT:BTI).

Does British American Tobacco have enough cash?
As private investors, we want to back businesses that are able to pay their dividends out of free cash flow each year. I define free cash flow as the cash that’s left over after capital expenditure, interest payments, and tax deductions. With that in mind, let’s look at British American Tobacco plc (LON:BATS)’s cash flow from the last five years:

Year 2008 2009 2010 2011 H1 2012
Free cash flow (millions of pounds) 753 2,713 3,461 3,274 876
Dividend payments (millions of pounds) 1,566 2,032 2,327 2,633 1,858
Free Cash Flow/Dividend* 0.5 1.3 1.5 1.2 0.5

Source: British American Tobacco annual reports. *A value of more than 1 means the dividend was covered by free cash flow.

Tobacco: The ultimate defensive investment?
British American Tobacco’s operations benefit from big efficiencies of scale and pricing power, which makes them impressively profitable: The company’s five-year average operating margin is 32.1%. As a result, BAT generates a lot of free cash flow, most of which has been returned to shareholders via dividends and share buybacks, both of which have been ramped up over the last five years.

BAT’s dividend has doubled since 2007, and the company spent $978 million on share buybacks in the first nine months of 2012 alone. Tobacco proved to be one of the safest and most attractive defensive investments during the financial crisis, and BAT’s share price has also risen, gaining 70% over the last five years — not bad for a FTSE 100 company.

Although much of British American Tobacco’s profitability is the result of its high profit margins, its powerful range of brands has also enabled it to expand into emerging markets and exert considerable pricing power across all of its markets. Smokers in emerging markets will happily spend a little extra to smoke a famous brand like Dunhill, Lucky Strike, or Pall Mall, and in the first half of last year, BAT delivered volume growth of 3% on its core “Global Drive Brands,” alongside 4% revenue growth which it said was driven by “continued good pricing,” by which it means the ability to control prices, rather than be controlled by them.

So is it too good to last?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!